Westport VP and general manager Paul Hemings spoke with DSN about the company's introduction of Zephrex-D, a meth-resistant pseudoephedrine product, to market. Beyond taking a bite out of the $23.5 billion methamphetamine trade, Hemings discussed the benefits of having Zephrex-D behind the pharmacy counter.
AUDIO Q&A: Westport VP and general manager Paul Hemings spoke with DSN about the company's introduction of Zephrex-D, a meth-resistant pseudoephedrine product, to market. Beyond taking a bite out of the $23.5 billion methamphetamine trade, Hemings discussed the benefits of having Zephrex-D behind the pharmacy counter.